|
시장보고서
상품코드
1423953
개용 백신 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 백신 유형별, 질병 유형별, 투여 경로별, 면역 기간별, 성분별, 지역별, 부문별 예측(2024-2032년)Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 개용 백신 시장 규모는 2032년까지 27억 828만 달러에 달할 것으로 예상됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
애견 백신 시장은 반려동물의 건강과 동물용 의약품 산업의 중요성이 커지면서 최근 몇 년동안 큰 폭의 성장세를 보이고 있습니다. 이러한 시장 성장의 원동력 중 하나는 반려견의 다양한 질병을 예방하는 백신 접종의 이점에 대한 보호자들의 인식이 높아진 것입니다. 더 많은 사람들이 반려견의 질병과 관련된 잠재적 위험에 대해 알게 되면서, 이러한 건강 위협으로부터 사랑하는 반려동물을 보호할 수 있는 효과적인 백신에 대한 수요가 증가하고 있습니다.
또한, 수의학 연구와 기술의 발전은 효능과 안전성이 향상된 혁신적인 백신의 개발을 촉진하고 있습니다. 이로 인해 예방 가능한 질병의 범위가 넓어졌을 뿐만 아니라 반려견 의료의 전반적인 질이 향상되었습니다. 수의학 전문가들은 나이, 품종, 생활습관 등의 요인을 고려하여 개 개개인의 고유한 요구에 맞는 맞춤형 백신 접종 프로토콜을 제공할 수 있는 능력을 그 어느 때보다 잘 갖추고 있습니다.
또한, 규제 당국의 이니셔티브와 공중보건 캠페인은 반려견 백신 시장의 역동성을 형성하는 데 있어 매우 중요한 역할을 하고 있습니다. 전 세계 정부 기관과 수의사 협회는 책임감 있는 반려동물 사육을 적극적으로 장려하고 예방 의료의 기초로서 정기적인 백신 접종의 중요성을 강조하고 있습니다. 이러한 공동의 노력은 보다 유리한 규제 환경과 동물용 백신 분야의 연구 및 개발에 대한 공공 자금 증가에 기여하고 있습니다.
또한, 반려동물의 인간화 추세는 반려견의 행복과 장수를 보장하는 백신을 포함한 첨단 의료 솔루션에 대한 수요를 더욱 증가시키고 있습니다. 반려동물 보호자들은 반려동물을 가족의 중요한 구성원으로 인식하고 있으며, 이에 따라 반려견이 더 건강한 삶을 영위할 수 있도록 예방적 조치에 기꺼이 투자하고 있습니다. 반려동물을 가족의 일원으로 여기는 이러한 문화적 변화는 백신 제조업체에 유리한 시장 기회를 창출하고, 끊임없는 기술 혁신과 제품 개발을 특징으로 하는 경쟁 환경을 조성하고 있습니다.
애개용 백신 시장 보고서 하이라이트
질병 예방에 도움이 되고 장기적인 면역력을 제공하기 때문에 약독화 백신 부문이 시장을 독점하고 있습니다.
광견병 부문은 높은 유병률과 인수공통전염병의 가능성으로 인해 빠른 속도로 성장할 것으로 보입니다.
APAC 지역은 반려동물의 수가 많고 반려동물에 대한 인식이 높아짐에 따라 가장 빠른 속도로 성장하고 있습니다.
목차
제1장 서론
- 보고서 설명
- 조사 목적
- 시장 범위
- 가정
- 이해관계자
제2장 주요 요약
제3장 조사 방법
제4장 세계의 개용 백신 시장 인사이트
- 개용 백신 시장 - 면역 기간 현황
- 개용 백신 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 개용 백신 시장 면역 기간 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 개용 백신 시장, 질환 유형별
- 주요 조사 결과
- 서론
- 디스템퍼
- 전염성 호흡기 질환 복합체(CIRDC)
- 파보바이러스증/파보바이러스 질병
- 렙토스피라증
- 라임병
- 전염성 간염
- 광견병
- 기타
제6장 세계의 개용 백신 시장, 백신 유형별
- 주요 조사 결과
- 서론
- Modified/ Attenuated Live
- Inactivated (Killed)
- 기타
제7장 세계의 개용 백신 시장, 면역 기간별
- 주요 조사 결과
- 서론
- 1년
- 3년
- 기타
제8장 세계의 개용 백신 시장, 지역별
- 주요 조사 결과
- 서론
- 개용 백신 시장 평가, 지역별, 2019-2032년
- 개용 백신 시장 - 북미
- 북미 : 개용 백신 시장, 질환 유형별, 2019-2032년
- 북미 : 개용 백신 시장, 면역 기간별, 2019-2032년
- 북미 : 개용 백신 시장, 백신 유형별, 2019-2032년
- 개용 백신 시장 - 미국
- 개용 백신 시장 - 캐나다
- 개용 백신 시장 - 유럽
- 유럽 : 개용 백신 시장, 질환 유형별, 2019-2032년
- 유럽 : 개용 백신 시장, 면역 기간별, 2019-2032년
- 유럽 : 개용 백신 시장, 백신 유형별, 2019-2032년
- 개용 백신 시장 - 영국
- 개용 백신 시장 - 프랑스
- 개용 백신 시장 - 독일
- 개용 백신 시장 - 이탈리아
- 개용 백신 시장 - 스페인
- 개용 백신 시장 - 네덜란드
- 개용 백신 시장 - 러시아
- 개용 백신 시장 - 아시아태평양
- 아시아태평양 : 개용 백신 시장, 질환 유형별, 2019-2032년
- 아시아태평양 : 개용 백신 시장, 면역 기간별, 2019-2032년
- 아시아태평양 : 개용 백신 시장, 백신 유형별, 2019-2032년
- 개용 백신 시장 - 중국
- 개용 백신 시장 - 인도
- 개용 백신 시장 - 말레이시아
- 개용 백신 시장 - 일본
- 개용 백신 시장 - 인도네시아
- 개용 백신 시장 - 한국
- 개용 백신 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 개용 백신 시장, 질환 유형별, 2019-2032년
- 중동 및 아프리카 : 개용 백신 시장, 면역 기간별, 2019-2032년
- 중동 및 아프리카 : 개용 백신 시장, 백신 유형별, 2019-2032년
- 개용 백신 시장 - 사우디아라비아
- 개용 백신 시장 - 아랍에미리트(UAE)
- 개용 백신 시장 - 이스라엘
- 개용 백신 시장 - 남아프리카
- 개용 백신 시장 - 라틴아메리카
- 라틴아메리카 : 개용 백신 시장, 질환 유형별, 2019-2032년
- 라틴아메리카 : 개용 백신 시장, 면역 기간별 개용 백신 시장,2019-2032
- 라틴아메리카 : 개용 백신 시장, 백신 유형별, 2019-2032년
- 개용 백신 시장 - 멕시코
- 개용 백신 시장 - 브라질
- 개용 백신 시장 - 아르헨티나
제9장 경쟁 구도
- 확장 및 인수 분석
- 확장
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Bioveta a.s
- Hester Biosciences Limited
- Boehringer Ingelheim International GmbH
- Brilliant Bio Pharma
- Heska Corporation
- Merck & Co., Inc.
- Virbac
- Zendal Group
- Elanco
- Zoetis Services
The global dog vaccine market size is expected to reach USD 2,708.28 million by 2032, according to a new study by Polaris Market Research. The report "Dog Vaccine Market Share, Size, Trends, Industry Analysis Report, By Vaccine Type, By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The dog vaccine market has experienced significant growth in recent years, driven by a combination of factors that underscore the increasing importance of pet health and the broader veterinary pharmaceutical industry. One of the primary driving forces behind this expansion is the rising awareness among pet owners about the benefits of vaccination in preventing various diseases in dogs. As more individuals become informed about the potential risks associated with canine illnesses, there is a heightened demand for effective vaccines that can safeguard their beloved pets from these health threats.
Furthermore, advancements in veterinary research and technology have facilitated the development of innovative vaccines with improved efficacy and safety profiles. This has not only expanded the range of diseases that can be prevented but also enhanced the overall quality of canine healthcare. Veterinary professionals are now better equipped than ever to provide tailored vaccination protocols that address the unique needs of individual dogs, considering factors such as age, breed, and lifestyle.
Additionally, regulatory initiatives and public health campaigns have played a pivotal role in shaping the dynamics of the dog vaccine market. Governmental organizations and veterinary associations across the globe have been actively promoting responsible pet ownership and emphasizing the importance of regular vaccinations as a cornerstone of preventive healthcare. These concerted efforts have contributed to a more favorable regulatory environment and increased public funding for research and development in the veterinary vaccine sector.
Moreover, the growing trend of humanization of pets has further propelled the demand for advanced healthcare solutions, including vaccines, to ensure the well-being and longevity of dogs. Pet owners are increasingly viewing their canine companions as integral members of their families and are therefore willing to invest in preventive measures that can help them lead healthier lives. This cultural shift towards treating pets as family members has created a lucrative market opportunity for vaccine manufacturers and has fostered a competitive landscape characterized by continuous innovation and product development.
Dog Vaccine Market Report Highlights
Attenuated vaccine segment dominated the market, as it helps in preventing disease and provides long term immunity
Canine rabies segment will grow at the rapid pace, primarily due to its high prevalence rate, and its zoonotic potential
APAC to grow at the fastest rate, owing to the presence of large number of pets in the region and growing awareness among pet owners
The global players include Bioveta, Hester Biosciences, Boehringer Ingelheim, Brilliant Bio Pharma, Heska Corp., Merck, Virbac, Elanco, and Zoetis Services
Polaris Market Research has segmented the dog vaccine market report based on vaccine type, disease type, duration of immunity, and region:
Dog Vaccine, Vaccine Type Outlook (Revenue - USD Million, 2019 - 2032)
- Modified/ Attenuated Live
- Inactivated (Killed)
- Others
Dog Vaccine, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)
- Canine Distemper
- Canine Infectious Respiratory Disease Complex (CIRDC)
- Canine Parvovirosis/ Parvovirus Disease
- Canine Leptospirosis
- Canine Lyme Disease
- Infectious Canine Hepatitis
- Canine Rabies
- Others
Dog Vaccine, Duration of Immunity Outlook (Revenue - USD Million, 2019 - 2032)
- 1-Year
- 3-Year
- Others
Dog Vaccine, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Dog Vaccine Market Insights
- 4.1. Dog Vaccine Market - Duration of Immunity Snapshot
- 4.2. Dog Vaccine Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Pet Adoption Rates
- 4.2.1.2. Advancements in Veterinary Medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Vaccines
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Dog Vaccine Market Duration of Immunity Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Dog Vaccine Market, by Disease Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 5.3. Canine Distemper
- 5.3.1. Global Dog Vaccine Market, by Canine Distemper, by Region, 2019-2032 (USD Million)
- 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
- 5.4.1. Global Dog Vaccine Market, by Canine Infectious Respiratory Disease Complex (CIRDC), by Region, 2019-2032 (USD Million)
- 5.5. Canine Parvovirosis/ Parvovirus Disease
- 5.5.1. Global Dog Vaccine Market, by Canine Parvovirosis/ Parvovirus Disease, by Region, 2019-2032 (USD Million)
- 5.6. Canine Leptospirosis
- 5.6.1. Global Dog Vaccine Market, by Canine Leptospirosis, by Region, 2019-2032 (USD Million)
- 5.7. Canine Lyme Disease
- 5.7.1. Global Dog Vaccine Market, by Canine Lyme Disease, by Region, 2019-2032 (USD Million)
- 5.8. Infectious Canine Hepatitis
- 5.8.1. Global Dog Vaccine Market, by Infectious Canine Hepatitis, by Region, 2019-2032 (USD Million)
- 5.9. Canine Rabies
- 5.9.1. Global Dog Vaccine Market, by Canine Rabies, by Region, 2019-2032 (USD Million)
- 5.10. Others
- 5.10.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)
6. Global Dog Vaccine Market, by Vaccine Type
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 6.3. Modified/ Attenuated Live
- 6.3.1. Global Dog Vaccine Market, by Modified/ Attenuated Live, by Region, 2019-2032 (USD Million)
- 6.4. Inactivated (Killed)
- 6.4.1. Global Dog Vaccine Market, by Inactivated (Killed), by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global Dog Vaccine Market, by Others, by Region, 2019-2032 (USD Million)
7. Global Dog Vaccine Market, by Duration of Immunity
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 7.3. 1-Year
- 7.3.1. Global Dog Vaccine Market, by 1-Year, By Region, 2019-2032 (USD Million)
- 7.4. 3-Year
- 7.4.1. Global Dog Vaccine Market, by 3-Year, By Region, 2019-2032 (USD Million)
- 7.5. Others
- 7.5.1. Global Dog Vaccine Market, by Others, By Region, 2019-2032 (USD Million)
8. Global Dog Vaccine Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Dog Vaccine Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. Dog Vaccine Market - North America
- 8.3.1. North America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.3.2. North America: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.3.3. North America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.3.4. Dog Vaccine Market - U.S.
- 8.3.4.1. U.S.: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.3.5. Dog Vaccine Market - Canada
- 8.3.5.1. Canada: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.3.5.3. Canada: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4. Dog Vaccine Market - Europe
- 8.4.1. Europe: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.3. Europe: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.4. Dog Vaccine Market - UK
- 8.4.4.1. UK: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.4.3. UK: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.5. Dog Vaccine Market - France
- 8.4.5.1. France: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.5.3. France: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.6. Dog Vaccine Market - Germany
- 8.4.6.1. Germany: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.6.3. Germany: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.7. Dog Vaccine Market - Italy
- 8.4.7.1. Italy: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.7.3. Italy: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.8. Dog Vaccine Market - Spain
- 8.4.8.1. Spain: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.8.3. Spain: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.9. Dog Vaccine Market - Netherlands
- 8.4.9.1. Netherlands: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.4.10. Dog Vaccine Market - Russia
- 8.4.10.1. Russia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.4.10.3. Russia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5. Dog Vaccine Market - Asia Pacific
- 8.5.1. Asia Pacific: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.4. Dog Vaccine Market - China
- 8.5.4.1. China: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.4.3. China: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.5. Dog Vaccine Market - India
- 8.5.5.1. India: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.5.3. India: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.6. Dog Vaccine Market - Malaysia
- 8.5.6.1. Malaysia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.7. Dog Vaccine Market - Japan
- 8.5.7.1. Japan: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.7.3. Japan: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.8. Dog Vaccine Market - Indonesia
- 8.5.8.1. Indonesia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.5.9. Dog Vaccine Market - South Korea
- 8.5.9.1. South Korea: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.6. Dog Vaccine Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.6.4. Dog Vaccine Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.6.5. Dog Vaccine Market - UAE
- 8.6.5.1. UAE: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.6.5.3. UAE: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.6.6. Dog Vaccine Market - Israel
- 8.6.6.1. Israel: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.6.6.3. Israel: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.6.7. Dog Vaccine Market - South Africa
- 8.6.7.1. South Africa: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.7. Dog Vaccine Market - Latin America
- 8.7.1. Latin America: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.7.3. Latin America: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.7.4. Dog Vaccine Market - Mexico
- 8.7.4.1. Mexico: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.7.5. Dog Vaccine Market - Brazil
- 8.7.5.1. Brazil: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
- 8.7.6. Dog Vaccine Market - Argentina
- 8.7.6.1. Argentina: Dog Vaccine Market, by Disease Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: Dog Vaccine Market, by Duration of Immunity, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: Dog Vaccine Market, by Vaccine Type, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Bioveta a.s
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. .Hester Biosciences Limited
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Boehringer Ingelheim International GmbH
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Brilliant Bio Pharma
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Heska Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Merck & Co., Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Virbac
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Zendal Group
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Elanco
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Zoetis Services
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
